Objective: To estimate the number of deaths among people released from prison in Australia in the 2007-08 financial year, within 4 weeks and 1 year of release.
Design, Participants And Setting: Application of crude mortality rates for ex-prisoners (obtained from two independent, state-based record-linkage studies [New South Wales and Western Australia]) to a national estimate of the number and characteristics of people released from prison in 2007-08.
Main Outcome Measures: Estimated number of deaths among adults released from Australian prisons in 2007-08, within 4 weeks and 1 year of release, classified by age, sex, Indigenous status and cause of death.
Results: It was estimated that among people released from prison in 2007-08, between 449 (95% CI, 380-527) and 472 (95% CI, 438-507) died within 1 year of release. Of these, between 68 (95% CI, 56-82) and 138 (95% CI, 101-183) died within 4 weeks of release. Most of these deaths were not drug-related.
Conclusion: The estimated annual number of deaths among recently released prisoners in Australia is considerably greater than the annual number of deaths in custody, highlighting the extreme vulnerability of this population on return to the community. There is an urgent need to establish a national system for routine monitoring of ex-prisoner mortality and to continue the duty of care beyond the prison walls.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5694/j.1326-5377.2011.tb03208.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
COVID-19 Testing Equity in New York City During the First 2 Years of the Pandemic: Demographic Analysis of Free Testing Data.
JMIR Public Health Surveill
March 2025
NYC Test & Treat Corps, The New York City Health + Hospitals Corporation, 50 Water St., New York, NY, 10004, United States, 1 212-788-3339, 1 212-788-3673.
Background: COVID-19 has caused over 46,000 deaths in New York City, with a disproportional impact on certain communities. As part of the COVID-19 response, the city has directly administered over 6 million COVID-19 tests (in addition to millions of indirectly administered tests not covered in this analysis) at no cost to individuals, resulting in nearly half a million positive results. Given that the prevalence of testing, throughout the pandemic, has tended to be higher in more affluent areas, these tests were targeted to areas with fewer resources.
View Article and Find Full Text PDFA meta-analysis of the efficacy and safety of immunomodulators in the treatment of severe COVID-19.
J Int Med Res
March 2025
Department of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan, China.
ObjectiveTo evaluate the efficacy and adverse events of immunomodulators in the treatment of severe coronavirus disease 2019 (COVID-19).MethodsA literature search for the meta-analysis was performed using PubMed, The Cochrane Library, Embase, Wanfang Data, CNKI, and Web of Science to identify randomized controlled trials assessing the outcomes of patients treated with corticosteroids alone and/or interleukin-6 receptor antagonists for COVID-19. The risk of bias was assessed using the Cochrane method.
View Article and Find Full Text PDFGlobal, regional and national burden of decubitus ulcers in 204 countries and territories from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021.
Front Public Health
March 2025
Department of Burns and Plastic Surgery, The 83 Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Background: Decubitus ulcers, also known as pressure ulcers, pose a significant public health challenge due to their substantial impact on morbidity, mortality, and healthcare expenditures.
Methods: The number and age-standardized rates (ASRs) of prevalence, death, disability adjusted life-year (DALY), years of life lost (YLL), and years lived with disability (YLD) at the global, regional, and national levels were acquired from the GBD 2021 database. Trends were evaluated based on the estimated average percentage change (EAPC) of ASRs.
Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression.
Biosaf Health
October 2024
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
The vaccinia virus Tiantan (VTT) is widely utilized as a smallpox vaccine in China and holds significant importance in the prevention of diseases stemming from poxvirus infections. Nevertheless, few studies have investigated the influence of VTT infection on host gene expression. In this study, we constructed time series transcriptomic profiles of HeLa cells infected with both VTT and western reserve (WR) strains.
View Article and Find Full Text PDFTooth loss trajectories and their association with all-cause mortality among older Chinese adults.
Front Oral Health
February 2025
Department of Emergency, The People's Hospital of Baoan Shenzhen, Shenzhen, China.
Background: The association between tooth loss trajectories and all-cause mortality has not been sufficiently explored. This study aims to examine the relationship between tooth loss trajectories and all-cause mortality in Chinese adults aged 65 years and older.
Methods: This study included 3,726 participants from the Chinese Longitudinal Healthy Longevity Study (CLHLS).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!